A Novel Targeting Drug Delivery System Based on Self-Assembled Peptide Hydrogel
- 1
- 2
- 3
- 4
- 5
- 6
- 7
Abstract
In the last two decades, 5-fluorouracil (5-FU) is widely used in clinical practice to inhibit the fibroblasts to proliferate and improve the success rate of glaucoma-filtering surgery, but 5-FU has many toxic effects to normal ocular tissues. The self-assembled peptide hydrogels may serve as a new class of biomaterials for applications including tissue engineering and drug delivery. How to deliver 5-FU quickly and precisely to the target sites of ocular tissue by a self-assembled peptide hydrogel remains unexplored. RGD (arginine-glycine-aspartic acid) sequence is cell attachment site in extracellular matrix (ECM). Thus, If the self-assembled peptide hydrogel containing the RGD sequence that act as a specific attachment site for the proliferated fibroblasts adhesion could be designed, after integrated 5-FU, a novel targeting drug delivery system will be put into practice in the future.
- P. J. Lama and R. D. Fechtner, “Antifibrotics and Wound Healing in Glaucoma Surgery,” Survey of Ophthalmology, Vol. 48, No. 3, 2003, pp. 314-346. doi:10.1016/S0039-6257(03)00038-9
- D. K. Heuer, R. K. Parrish 2nd, M. G. Gressel, E. Hodapp, P. F. Palmberg and D. R. Anderson, “5-Fluorouracil and Glaucoma Filtering Surgery. I. A Pilot Study,” Ophthalmology, Vol. 91, No. 4, 1984, pp. 384-394.
- G. L. Skuta, C. C. Beeson, E. J. Higginbotham, P. R. Lichter, D. C. Musch, T. J. Bergstrom, T. B. Klein and F. Y. Falck Jr., “Intraoperative Mitomycin versus Postoperative 5-Fluorouracil in High-Risk Glaucoma Filtering Surgery,” Ophthalmology, Vol. 99, 1992, pp. 438-444.
- C. Akarsu, M. Onol and B. Hasanreisoglu, “Postoperative 5-Fluorouracil versus Intraoperative Mitomycin c in High-Risk Glaucoma Filtering Surgery: Extended Follow up,” Clinical & Experimental Ophthalmology, Vol. 31, No. 3, 2003, pp. 199-205. doi:10.1046/j.1442-9071.2003.00645.x
- G. A. Silva, C. Czeisler, K. L. Niece, E. Beniash, D. A. Harrington, J. A. Kessler and S. I. Stupp, “Selective Differentiation of Neural Progenitor Cells by High-Epitope Density Nanofibers,” Science, Vol. 303, No. 5662, 2004, pp. 1352-1355. doi:10.1126/science.1093783
- S. Zhang, “Emerging Biological Materials through Molecular Self-Assembly,” Biotechnology Advances, Vol. 20, No. 5-6, 2002, pp. 321-339. doi:10.1016/S0734-9750(02)00026-5
- S. Zhang, “Fabrication of Novel Biomaterials through Molecular Self-Assembly,” Nature Biotechnology, Vol. 21, 2003, pp. 1171-1178. doi:10.1038/nbt874
- C. Keyes-Baig, J. Duhamel, S. Y. Fung, J. Bezaire and P. Chen, “Self-Assembling Peptide as a Potential Carrier of Hydrophobic Compounds,” Journal of the American Chemical Society, Vol. 126, No. 24, 2004, pp. 7522-7532. doi:10.1021/ja0381297
- Z. Yang, G. Liang, M. Ma, A. S. Abbah, W. W. Lu and B. Xu, “D-Glucosamine-Based Supramolecular Hydrogels to Improve Wound Healing,” Chemical Communications, No. 8, 2007, pp. 843-845. doi:10.1039/b616563j
- P. K. Vemula, G. A. Cruikshank, J. M. Karp and G. John, “Self-Assembled Prodrugs: An Enzymatically Triggered Drug-Delivery Platform,” Biomaterials, Vol. 30, No. 3, 2009, pp. 383-393. doi:10.1016/j.biomaterials.2008.09.045
- M. D. Pierschbacher and E. Ruoslahti, “Cell Attachment Activity of Fibronectin Can Be Duplicated by Small Synthetic Fragments of the Molecule,” Nature, Vol. 309, 1984, pp. 30-33. doi:10.1038/309030a0